Northwest Biotherapeutics, Inc. (NASDAQ:NWBO) Consolidated Diluted EPS At -1.4765

0

For the year ended 2015-12-31 Northwest Biotherapeutics, Inc. (NASDAQ:NWBO) basic consolidated EPS came $-1.4765. Furthermore, for the quarter closed 2015-12-31, it was $-1.4765.

Consolidated diluted EPS

Northwest Biotherapeutics, Inc. (NASDAQ:NWBO) consolidated diluted EPS was -1.4765 for the year ended 2015-12-31. For the quarter ended 2015-12-31, it stood at $-1.4765.

EPS contribution from parent

Northwest Biotherapeutics, Inc. (NASDAQ:NWBO) basic EPS was $-1.4765 for the year ended 2015-12-31 from its parent entity. It was $-1.4765 for the quarter closed 2015-12-31.

EPS from continuing operations

Northwest Biotherapeutics, Inc. (NASDAQ:NWBO) EPS from continuing activities was $-1.4765 for the fiscal ended 2015-12-31. For the quarter ended 2015-12-31, this figure was $-1.4765.

Basic net EPS

Northwest Biotherapeutics, Inc. (NASDAQ:NWBO) basic net EPS was $-1.48 for the year ended 2015-12-31. For the quarter ended 2015-12-31, it came at $-1.48.

Diluted EPS from parent

Northwest Biotherapeutics, Inc. (NASDAQ:NWBO) diluted EPS from parent entity came at $-1.4765 for the year ended 2015-12-31. For the quarter ended 2015-12-31 it was $-1.4765.

Net diluted EPS

Northwest Biotherapeutics, Inc. (NASDAQ:NWBO) net diluted EPS was $-1.48 for the fiscal closed 2015-12-31. For the quarter ended 2015-12-31, net diluted EPS was $-1.48.

Northwest Biotherapeutics, Inc. (NASDAQ:NWBO) net basic EPS was $-1.4288 for the year ended 2015-12-31. For the quarter ended 2015-12-31, it was $-1.4288.

Basic diluted EPS

Northwest Biotherapeutics, Inc. (NASDAQ:NWBO) basic diluted EPS was $-0.0625 for the quarter ended 2015-12-31. For the year ended 2015-12-31, basic diluted EPS was $-0.0625.

For the year ended 2015-12-31, basic shares outstanding were 32.865 while for the quarter ended 2015-12-31 is 32.865.

For the fiscal ended 2015-12-31, the diluted outstanding shares were 32.865 and for the quarter ended 2015-12-31 it was 32.865. Earnings per share and diluted EPS are profitability metrics used in fundamental analysis of firms. EPS just takes into account a firm’s common shares, while diluted EPS considers all convertible securities. Per-share earnings measure the quantum of a company’s earnings on a per share basis. Basic EPS does not consider any dilutive impact that convertible securities leave on EPS. On contrary, diluted EPS is a tool used in fundamental study to gauge a firm’s quality of EPS, assuming there is conversion of all convertible securities.

1 Chart Pattern Every Investor Should Know

This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...

Click Here to See This Now.

(Visited 56 times, 1 visits today)